Ritlecitinib Generally Well-Tolerated in Pediatric Patients with Alopecia, According to Phase 1 Study Dermatology Times, 20 Feb 2025 Image Credit: © littlewolf1989 - stock.adobe.com A phase 1 study measured the pharmacokinetic and safety parameters in…